ED
NUE icon

Exane Derivatives’s Nucor NUE Stock Holding History

Exane Derivatives’s Portfolio NUE Stock Details NUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$549K Buy
5,256
+884
+20% +$120K 0.32% 74
2022
Q1 		$650K Buy
4,372
+1,239
+40% +$152K 0.18% 149
2021
Q4 		$358K Sell
3,133
-90
-3% -$9.84K 0.09% 228
2021
Q3 		$317K Sell
3,223
-3,716
-54% -$395K 0.08% 273
2021
Q2 		$661K Buy
6,939
+6,805
+5,078% +$637K 0.15% 137
2021
Q1 		$10.8K Sell
134
-1,055
-89% -$63.9K ﹤0.01% 596
2020
Q4 		$63.2K Sell
1,189
-758
-39% -$39.1K 0.02% 442
2020
Q3 		$87.3K Buy
1,947
+224
+13% +$9.92K 0.03% 315
2020
Q2 		$71.4K Sell
1,723
-501
-23% -$20.2K 0.02% 328
2020
Q1 		$80.1K Sell
2,224
-63,994
-97% -$2.84M 0.02% 306
2019
Q4 		$3.54M Sell
66,218
-2,449
-4% -$134K 0.66% 47
2019
Q3 		$3.5M Buy
68,667
+365
+0.5% +$19.1K 0.63% 38
2019
Q2 		$3.76M Buy
68,302
+4,737
+7% +$260K 0.66% 37
2019
Q1 		$3.71M Buy
63,565
+61,236
+2,629% +$3.59M 0.73% 45
2018
Q4 		$121K Hold
2,329
– – 0.02% 302
2018
Q3 		$148K Buy
2,329
+794
+52% +$50.8K 0.03% 275
2018
Q2 		$95.9K Buy
1,535
+77
+5% +$4.92K 0.02% 338
2018
Q1 		$86.1K Buy
1,458
+300
+26% +$19.9K 0.02% 317
2017
Q4 		$73.6K Buy
1,158
+78
+7% +$4.56K 0.01% 315
2017
Q3 		$60.5K Sell
1,080
-20
-2% -$1.13K 0.01% 294
2017
Q2 		$63.6K Buy
1,100
+673
+158% +$39.5K 0.01% 302
2017
Q1 		$25.5K Buy
427
+424
+14,133% +$25.9K 0.01% 316
2016
Q4 		$179 Sell
3
-164,110
-100% -$9.18M ﹤0.01% 513
2016
Q3 		$8.11M Buy
+164,113
New +$8.35M 1.22% 24

Other funds holding NUE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Exane Derivatives's NUE Position: Q2 2022 in Review

Exane Derivatives increased its Nucor (NUE) stake by 20% in Q2 2022, buying an estimated $120K and bringing the position to 5,256 shares worth $549K. The position accounts for 0.32% of the portfolio, ranked #74.

Exane Derivatives first reported a position in NUE in Q3 2016 and has held it in 24 quarters since. The position peaked at $8.11M in Q3 2016. 1,072 funds tracked by Wall St. Rank hold NUE as of Q2 2022.

  • Exane Derivatives held 5,256 shares of Nucor worth $549K as of Q2 2022.
  • Exane Derivatives bought 884 Nucor shares in Q2 2022, an estimated $120K.
  • Nucor made up 0.32% of Exane Derivatives's portfolio in Q2 2022, its #74 holding.
  • Exane Derivatives first reported a position in Nucor in Q3 2016 and has held it in 24 quarters since.
  • Exane Derivatives's Nucor position peaked at $8.11M in Q3 2016.
  • 1,072 funds tracked by Wall St. Rank held Nucor as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.